Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)

Hong Kong · Delayed Price · Currency is HKD

28.80

+0.30 (1.05%)

At close: Sep 4, 2026

HKG:9637 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	122.6	30.56	6.53
Revenue Growth	-	368.29%	-
Gross Profit	99.27	13.45	2.39
Operating Income	-623.05	-646.76	-310.27
Net Income	-703.81	-750.04	-326.03
Earnings Per Share	-2.58	-3.07	-1.20
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1,394	532	366.17
Total Debt	576.64	549.42	479.15
Net Cash (Debt)	817.36	-17.42	-112.98
Net Cash Growth	-	-	-
Net Cash Per Share	3.00	-0.07	-0.42

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-	-287.89	-249.9
Capital Expenditures	-	-101.62	-230.63
Free Cash Flow	-	-389.51	-480.52
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	80.97%	44.00%	36.55%
Operating Margin	-508.18%	-2116.64%	-4755.03%
Pretax Margin	-574.79%	-2460.46%	-5136.09%
Profit Margin	-574.05%	-2454.63%	-4996.57%
FCF Margin	-	-1274.74%	-7364.34%